Substituted pyrrolo[2,3-d]pyrimidines as CK2 inhibitors

hawafiz kfu icon
book cover

Substituted pyrrolo[2,3-d]pyrimidines as CK2 inhibitors

  • US 11,945,823 B1

  • الصحة - Health

  • 2024

  • مكتب البراءات الأمريكي - US Patent Office

  • Haroun; Michelyne (Al-Ahsa, SA), Tratrat; Christophe (Al-Ahsa, SA)

  • Pyrrolo[2,3-d]pyrimidine compounds, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The pyrrolo[2,3-d]pyrimidine compounds, identified as CK2 inhibitors, are useful as anticancer and/or antitumor agents, and as agents for treating other kinase-associated conditions including inflammation, pain, and certain immunological disorders, and other types of diseases such as diabetes, viral infection, neurodegenerative diseases. The pyrrolo[2,3-d]pyrimidine compounds include compounds of the general formula: ##STR00001##